Flávia de Freire Cassia

Flávia de Freire Cassia

Auto-generated profile, based on publicly available information

Flávia de Freire Cassia

Sector of Dermatology, Post-Graduation Course in Dermatology, University Hospital and School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2018 in Advances in Rheumatology
Verified
Journal Article
Open access
PDF file
AMAlexandre Sampaio Moura
Alexandre Sampaio Moura
RSRafael Pereira dos Santos
Rafael Pereira dos Santos
JMJean Misse
Jean Misse
DSDiego Marcos De Souza
Diego Marcos De Souza
FOFernanda Sales De Oliveira
Fernanda Sales De Oliveira
ARAntonio Luiz Ribeiro
Antonio Luiz Ribeiro

1 May 2021 in Psoriasis: Targets and Therapy
Verified
Journal Article
Open access
PDF file
FCFlavia de Freire Cassia
Flavia de Freire Cassia
JCJuliana Fernandes Cardoso
Juliana Fernandes Cardoso
LPLuis Cristóvão Porto
Luis Cristóvão Porto
MRMarcia Ramos-E-Silva
Marcia Ramos-E-Silva
SCSUELI CARNEIRO
SUELI CARNEIRO
Background: The study of HLA classes I and II in Brazilian psoriasis patients may contribute to a better understanding of their association with the disease. Objective: To describe HLA classes I and II of Brazilian patients with psoriasis, with or without arthritis, compare them to controls and correlate HLA markers with epidemiological and evolutional aspects of psoriasis. Methods: A total of 55 patients with more than 5 years of psoriasis, with or without arthritis, answered a questionnaire on ethnic background and disease severity. A total of 134 bone marrow donors were controls. HLA class I and II genotyping was determined by PCR-SSP. Results: Mean age was 42.4 years; 23 women and 32 men. HLA-B*57 was present in 23.6% patients and in 7.5% controls (p=0.00200, OR= 3.8381), and HLA-C*06 in 29.1% patients and in 16.4% controls (p= 0.04832, OR=2.0886). HLA-B*57 and HLA-C*18 were significantly present in patients with arthritis (p=0.00104, OR=6.6769 and p=0.00269, OR=16.50, respectively). HLA-B*57 was significantly present in patients with history of erythroderma (p=0.00548, OR= 5.1059), as was HLA-C*06 (p=0.02158, OR=3.0545). HLA-B*57 was also frequent in patients with history of hospital internment due to psoriasis (p= 0.00094, OR=7.8909) and in the ones with history of systemic treatment for psoriasis (p= 0.00011, OR= 5.3733). Haplotype HLA-A*02 B*57 C*06 DRB1*07DQB1*03 was the most common among the patients (p= 0.00069, OR= 3.528). Conclusion: HLA-B*57 and HLA-C*06 were significantly increased in the patients indicating risk for psoriasis. HLA-B*57 remained high in patients with history of erythroderma, hospital internment, systemic treatment, and psoriatic arthritis, showing association with disease severity. HLA-C*18 was significantly high only in patients with psoriatic arthritis. HLA-B*57 and HLA-C*06 and haplotype HLA-A*02B*57Cw*06DRB1*07 DQB1*03 seen in this study were already described before, associated with psoriasis. HLA-Cw*18 was not described in other populations in association with psoriasis.

19 March 2020 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
PDF file
KSKarilena Fernandes Souza
Karilena Fernandes Souza
PAPaulo Fernando Barbosa de Camargo Andrade
Paulo Fernando Barbosa de Camargo Andrade
FCFlávia de Freire Cassia
Flávia de Freire Cassia
MCMaria Cristina Ribeiro de Castro
Maria Cristina Ribeiro de Castro

1 May 2020 in Anais Brasileiros de Dermatologia (Versão em Português)
Verified
Journal Article
Open access
KSKarilena Fernandes Souza
Karilena Fernandes Souza
PAPaulo Fernando Barbosa de Camargo Andrade
Paulo Fernando Barbosa de Camargo Andrade
FCFlávia de Freire Cassia
Flávia de Freire Cassia
MCMaria Cristina Ribeiro de Castro
Maria Cristina Ribeiro de Castro

21 February 2026 in Anais Brasileiros de Dermatologia (Versão em Português)
Verified
Journal Article
Open access
ASAna Luisa Sampaio
Ana Luisa Sampaio
BRBruna Romana-Souza
Bruna Romana-Souza
HMHaizza Monteiro
Haizza Monteiro
JNJeane de Souza Nogueira
Jeane de Souza Nogueira
DSDanielle Angst Secco
Danielle Angst Secco
LPLuis Cristóvão Porto
Luis Cristóvão Porto

1 May 2020 in Journal of the Portuguese Society of Dermatology and Venereology
Verified
Journal Article
Open access
PDF file
NSN. A. Sousa
N. A. Sousa
MBM. O. Buffara
M. O. Buffara
RMR. L. Maia
R. L. Maia
APA. S. Pessoa
A. S. Pessoa
FCFf Cassia
Ff Cassia
ABA. M. Brotas
A. M. Brotas
Linfomas cutâneos primários são definidos como um grupo heterogéneo de neoplasias malignas linfoproliferativas que acometem a pele, sem evidência de envolvimento extracutâneo no momento do diagnóstico. O subgrupo “linfoma cutâneo primário de grandes células B, tipo perna (PCLBCL, LT)” geralmente acomete um ou ambos membros inferiores, porém 10% - 15% dos casos apresentam lesões em outros locais. Apresenta-se um caso raro de PCLBCL, LT com lesão nodular na região cervical posterior, enfatizando sua apresentação atípica. Considerando o crescimento rápido da lesão e o alto índice proliferativo, é importante conhecer todas as possíveis apresentações clínicas para assim realizar o diagnóstico precoce e instituir o tratamento efetivo.